A New Corporate Structure for a Changing Risk Landscape
In July 2026, the Monetary Authority of Singapore issued a consultation paper proposing a legislative framework for a new Protected Cell Company corporate structure, designed to support the growth of alternative risk transfer solutions and deepen Singapore’s role as a risk management hub. The framework addresses a practical constraint: under current rules, risk owners must set up individual legal entities such as special purpose vehicles to legally ringfence capital, assets and liabilities for each risk programme, and the effort and cost involved can deter broader adoption of these solutions.
A PCC operates as a single legal entity comprising a central “Core” and one or more separate and distinct “Cells.” The assets and liabilities of each Cell are legally segregated from those of other Cells and the Core, allowing multiple insurance solutions to be managed independently within a single structure while the Core provides centralised governance and oversight.
The rationale is compelling. In 2025, natural disasters caused approximately USD 65 billion in economic losses across Asia, and more than 90% of these were uninsured. As Deputy Prime Minister Gan Kim Yong noted, risks today are more complex, more connected and harder to price, and Asia remains significantly underinsured. The PCC framework is designed to support captive insurance, insurance-linked securities and sovereign risk pools — three areas where Singapore aims to become a regional hub.
Captives, ILS and the Regional Opportunity
For captive insurance, the PCC framework allows companies to establish dedicated captives where multiple self-insuring programmes run through separate cells within a common umbrella core, or to participate in “rent-a-captive” solutions using a segregated cell within a shared captive facility. This reduces setup and operating costs, increasing accessibility for smaller firms that would otherwise find captive solutions commercially unviable.
For insurance-linked securities, insurers can tap capital markets to secure additional risk-bearing capacity by issuing ILS through separate cells without establishing a new special purpose vehicle for each transaction. This enables faster execution, lowers issuance costs and makes smaller or more bespoke transactions — such as sidecars and collateralised reinsurance — more viable. For sovereign risk pools, PCCs can support insurance facilities that pool risks across multiple countries or participants, such as disaster risk financing initiatives.
The consultation closed on 7 August 2026, with MAS indicating that the proposed draft PCC Act and subsidiary legislation would be consulted on at a later stage.
RBC 2 Adjustments and Capital Efficiency
Alongside the PCC framework, MAS is expected to implement another round of adjustments to its Risk-Based Capital 2 regime before the end of 2026, as risks, market practices and international standards evolve. The RBC 2 regime is a critical determinant of how much capital insurers must hold against different product lines and asset classes. Adjustments can shift the relative attractiveness of participating policies versus unit-linked products, or alter the economics of long-term care and annuity offerings.
For life insurers navigating a lower-for-longer yield environment, RBC 2 refinements could provide welcome flexibility in product pricing and capital allocation. For general insurers, the focus is likely to remain on underwriting discipline and claims management, particularly in motor and health lines where medical inflation reached 10.1% in 2024 and is projected at 16.9% for 2026.
The Regulatory Balance
MAS’s approach reflects a deliberate balance between fostering innovation and maintaining prudential stability. The extension of Fair Dealing Guidelines to every financial institution sharpens product-suitability standards and fosters trust, while regulatory sandboxes allow insurtech entrants to test new models under supervision. The PCC framework consultation, which was open to interested parties, exemplifies this consultative approach.
The broader strategic context is Singapore’s ambition to be a trusted connector in a changing world — a jurisdiction where capital, risk and innovation can meet efficiently. The PCC framework is not simply a technical corporate structure; it is an infrastructure play designed to attract risk owners, insurers and capital markets participants who might otherwise choose Bermuda, the Cayman Islands or Dublin. Whether it succeeds will depend on the final legislative details and the speed with which MAS can operationalise the framework.
For insurers already operating in Singapore, the regulatory trajectory signals that product innovation will increasingly extend beyond retail life and health into corporate risk transfer, captives and ILS. The firms that build expertise in these areas early will be positioned to capture a growing share of Asia’s underinsured risk.
